Azotemia is a biochemical abnormality that refers to an elevation of blood urea nitrogen (BUN) and creatinine levels, related largely to a decreased glomerular filtration rate (GFR). It is a typical feature of both acute and chronic kidney injury. Prerenal azotemia is encountered when there is hypoperfusion of the kidneys that impairs renal function in the absence of parenchymal damage. Postrenal azotemia is seen whenever urine flow is obstructed
Acute kidney injury is characterized by rapid decline in GFR within hours to days with concurrent dysregulation of fluid and electrolyte balance, and retention of metabolic waste products normally excreted by the kidney including urea and creatinine
Nephritic syndrome is caused by inflammatory glomerular disease and is dominated by the acute onset of either grossly visible hematuria or microscopic hematuria with dysmorphic red cells and red cell casts on urinalysis, diminished GFR, mild to moderate proteinuria, and hypertension
Renal diseases are responsible for a great deal of morbidity and mortality, with more than 660,000 Americans having end-stage renal disease (ESRD) in 2015, two-thirds maintained on dialysis at a cost of approximately $72,000 per person annually
Chronic kidney disease is defined as the presence of a diminished GFR persistently less than 60 mL/min/1.73 m2 for at least 3 months, from any cause, and/or persistent albuminuria
Nephrotic syndrome is characterized by heavy proteinuria (more than 3.5 g/day), hypoalbuminemia, severe edema, hyperlipidemia, and lipiduria (lipid in the urine)
Human kidneys convert more than 1700 L of blood per day into about 1 L of highly concentrated fluid called urine, excreting waste products of metabolism, regulating the body’s concentration of water, salt, calcium, phosphorus, and other anions and cations, and maintaining the appropriate acid-base balance of plasma
Millions of people are affected annually by nonfatal kidney diseases, including infections of the kidney or lower urinary tract, kidney stones, and urinary obstruction
NC1 domain in the collagenous suprastructure is important for helix formation and assembly of collagen monomers into the basement membrane suprastructure
Chronic kidney disease affects 11% of all adults in the United States, predominantly older adults, end result of various renal diseases, commonly diabetes and hypertension, major cause of death from renal disease
Evolution from normal renal function to symptomatic chronic kidney injury progresses through stages defined by measures of serum creatinine, estimates of reduction in GFR
Glomerular basement membrane (GBM) consists of collagen (mostly type IV), laminin, polyanionic proteoglycans (mostly heparan sulfate), fibronectin, entactin, and several other glycoproteins
Azotemia is the biochemical manifestation of acute or chronic kidney injury characterized by elevated 1DN or elevated serum creatinine, reflecting a reduction in GFR
Acute kidney injury can be reversible or progress to chronic kidney disease, generally irreversible
Nephrotic syndrome results in abnormal filtration, leading to heavy proteinuria, edema, and metabolic disturbances
Nephritic syndromes involve hematuria, azotemia, hypertension, and sub-nephrotic proteinuria
Diseases involving tubules and interstitium may have manifestations of nephritic syndrome, specific defects in tubular function, or acute/chronic kidney disease without defining features
End-stage renal disease has GFR less than 5% of normal, the terminal stage of uremia
Renal tubular defects are dominated by polyuria, nocturia, and electrolyte disorders, result of diseases affecting tubular structures or causing defects in specific tubular functions
Urinary tract obstruction and renal tumors have varied clinical manifestations based on specific anatomic location and nature of the lesion
Urinary tract infection characterized by bacteriuria and pyuria, may affect kidney (pyelonephritis) or bladder (cystitis)
Nephrolithiasis manifested by severe pain (renal colic) and hematuria, often with recurrent stone formation